Ruffer LLP Jazz Pharmaceuticals PLC Transaction History

Ruffer LLP

$2.68 Billion
Q4 2024

A detailed history of Ruffer LLP transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Ruffer LLP holds 58,767 shares of JAZZ stock, worth $7.99 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

58,767

Holding current value

$7.99 Million

% of portfolio

0.27%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 07, 2025	BUY	$107.32 - $127.74 $6.31 Million - $7.51 Million	58,767 New	58,767 $7.24 Million
Q2 2021 Aug 06, 2021	BUY	$160.2 - $186.42 $1.23 Million - $1.44 Million	7,702 New	7,702 $1.37 Million

Others Institutions Holding JAZZ

# of Institutions

543

Shares Held

59M

Call Options Held

125K

Put Options Held

58.4K

Black Rock Inc. New York, NY

6.15M
Shares

$836 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

6.04M
Shares

$821 Million
0.01% of portfolio
Lsv Asset Management Chicago, IL

2.53M
Shares

$344 Million
0.72% of portfolio
Pacer Advisors, Inc. Malvern, PA

2.21M
Shares

$301 Million
0.67% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.04M
Shares

$277 Million
0.06% of portfolio

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $8.53B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ruffer LLP, based on Form 13F filings with the SEC.

News

Stay updated on Ruffer LLP with notifications on news.

Account